Private-AI funding froth, concentration risks, and AI-credit spillover
Key Questions
What is OpenAI's valuation and funding?
OpenAI reaches $852B valuation amid AI froth, with $600M unsold shares in secondaries. Q1 VC hits $300B driven by AI boom.
What acquisitions is Anthropic making?
Anthropic acquires Coefficient Bio, an 8-month-old AI drug startup, for $400M in shares despite <10 employees. Marks bold AI-pharma tuck-in.
How is Google entering AI cyber?
Google finalizes $32B Wiz cybersecurity acquisition, bolstering AI/cloud security. Wiz deal closed after prior talks.
What Nvidia AI investments stand out?
Nvidia's $2B Marvell deal and $50B bet on Thinking Machines Lab (ex-OpenAI CTO) raise stakes. $10B TPG JV adds to concentration.
How are secondaries repricing AI assets?
$2B chasing Anthropic shares, OpenAI unsold $600M show secondaries repricing AI race. Reflects investor sentiment shifts.
What VC records in Q1 2026?
Q1 2026 shatters VC records at $300B, propelled by AI funding froth. Includes MatX $500M Jane St chips.
What risks from AI concentration?
40% software disrupt, NV DCs/RWAs/gridlock, FOs 86% ops exposure highlight spillover to AI-credit. Private-AI funding froth risks bubbles.
What is KKR's AI push?
KKR leads $90M Series C in Coder for secure AI dev, contrasting valuation concerns. Part of broader AI infra investments.
OpenAI $852B/MatX $500M Jane St AI chips/Nvidia $2B Marvell/$10B TPG JV/Anthropic $380B $400M Coefficient Bio tuck-in/Google $32B Wiz cyber/Wiz closed; Q1 VC $300B; secondaries repricing; 40% software disrupt; FOs 86% ops/NV DCs/RWAs/gridlock.